American journal of hypertension · 2026
Hemodynamic evolution of heart failure from hypertension: lower stroke volume index and higher heart rate.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Izzo Joseph L, Srungavarapu Sambasiva R, Khatri Chander P, Shalini Fnu, Osmond Peter J
Аннотация
BACKGROUND: There is little information about systemic hemodynamic changes in the evolution of heart failure (HF) from hypertension.
METHODS: We compared 24-hour mean hemodynamic variables derived from ambulatory pulse wave analysis (Mobil-O-Graph) in at-risk patients with hypertension (Stage A/B HF) and patients with Stage C HF secondarily stratified by ejection fraction (EF: low <40% or high ≥40%).
RESULTS: Differences (mean ± SEM) between Stage A/B (n = 109) and Stage C HF (n = 52) were, respectively: stroke volume index (SVI) 36.8 vs. 31.9 mL/m2 (P < .001), heart rate (HR) 68.1 vs. 76.4 bpm (P < .001), and arterial stiffness (pulse pressure/SVI) 1.47 vs. 1.65 mmHg/mL/m2 (P < .05); cardiac index and total vascular resistance index did not differ between groups. Robust inverse correlations between SVI and HR were found in both Stage A/B and Stage C HF (P < .001); each 10 beat/min change in HR was accompanied by a reciprocal SVI change of 3 mL/m2; overall, SVI was 5%-10% lower in Stage C compared to Stage A/B HF. Hemodynamic profiles, especially high HR and low SVI, were quantitatively similar in Stage C HF patients with low or high EF. Low SVI (<35 mL/min/m2) conferred a specificity for Stage C HF of 71%; adding high HR (>75 bpm) increased specificity to 84%.
CONCLUSIONS: Ambulatory hemodynamic monitoring is feasible in HF patients; low 24-hour SVI and high HR are highly correlated and together can differentiate Stage C from Stage A/B HF, irrespective of EF. Further study of hemodynamic profiles in HF staging and prognosis is warranted.
METHODS: We compared 24-hour mean hemodynamic variables derived from ambulatory pulse wave analysis (Mobil-O-Graph) in at-risk patients with hypertension (Stage A/B HF) and patients with Stage C HF secondarily stratified by ejection fraction (EF: low <40% or high ≥40%).
RESULTS: Differences (mean ± SEM) between Stage A/B (n = 109) and Stage C HF (n = 52) were, respectively: stroke volume index (SVI) 36.8 vs. 31.9 mL/m2 (P < .001), heart rate (HR) 68.1 vs. 76.4 bpm (P < .001), and arterial stiffness (pulse pressure/SVI) 1.47 vs. 1.65 mmHg/mL/m2 (P < .05); cardiac index and total vascular resistance index did not differ between groups. Robust inverse correlations between SVI and HR were found in both Stage A/B and Stage C HF (P < .001); each 10 beat/min change in HR was accompanied by a reciprocal SVI change of 3 mL/m2; overall, SVI was 5%-10% lower in Stage C compared to Stage A/B HF. Hemodynamic profiles, especially high HR and low SVI, were quantitatively similar in Stage C HF patients with low or high EF. Low SVI (<35 mL/min/m2) conferred a specificity for Stage C HF of 71%; adding high HR (>75 bpm) increased specificity to 84%.
CONCLUSIONS: Ambulatory hemodynamic monitoring is feasible in HF patients; low 24-hour SVI and high HR are highly correlated and together can differentiate Stage C from Stage A/B HF, irrespective of EF. Further study of hemodynamic profiles in HF staging and prognosis is warranted.